The effectiveness of Mometasone Furoate plus Isotonic Nasal Saline in the Elderly with Rhinitis
Not Applicable
- Conditions
- Chronic rhinitisJ31.0
- Registration Number
- RBR-498bnq
- Lead Sponsor
- Programa de Pós Graduação em Ciências Médicas da Universidade Federal Fluminense
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Adults with symptoms of chronic rhinitis, two or more symptoms of nasal blockage, rhinorrhea, sneeze or nasal itching for 1 hour or more and for two weeks or more; age equal or above 60 years old; monitored clinically in the departament of allergy and immunology of Hospital Universitário Antônio Pedro.
Exclusion Criteria
Primary or secondary immunodeficiency; mechanical obstruction of upper airways; respiratory infection in the last two weeks; impossible to perform spirometry before and after bronchodilator.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in nasal patency of the elderly with rhinitis after two weeks of treatment assessed by the peak nasal inspiratory flow (PNIF). That is, increase of at least 30 L/min in the PNIF after two weeks of treatment.
- Secondary Outcome Measures
Name Time Method Reduction of at least 15 points in the sinonasal outcome test (SNOT-22) of the elderly with rhinitis after two weeks of treatment;Reduction of at least 2 points in the severity of symptoms assessed by a 10-point visual analogic scale (VAS) of the elderly with rhinitis after two weeks of treatment